Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Leo Pharma sets out its social media principles

Also expands its use of Twitter with two newaccounts

Leo Pharma corporate Twitter account 

Leo Pharma this month launched two new Twitter accounts to continue efforts that include publishing its social media principles. 

These state the company's desire to share information but, as would be expected given European marketing codes, won't see it "discuss or provide diagnosis of a skin condition". 

"Due to regulations, we cannot discuss pharmaceutical products. All content must be factual and non-promotional," the social media principles state.  Unsurprisingly too, the company plans to verify any external websites and links before it shares them.

The principles go on to explain that the company plans to be social in its use if social media (something that pharma often struggles with): "We will endeavour to respond to @ mentions and/or replies and ensure that any factually incorrect information shared is corrected as soon as possible.

"As a pharmaceutical company, Leo Pharma is not in a position to diagnose a skin condition or provide advice on how they should be managed, including recommending any treatments." 

Nevertheless, the company, which earlier this year submitted an aerosol foam treatment for plaque psoriasis for US approval, does want to have a dialogue on skin issues.

Adding to the @LeoHealthySkin Twitter account it started last September, Leo this month started tweeting from its new corporate @LeoPharmaCh account and the psoriasis-focused @LeoPharmaCh_pso.

26th March 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics